Chembio Diagnostics, Inc.
|Number of Estimates|
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.
Market Cap: 219 Million
Primary Exchange: NASDAQ
Shares Outstanding: 20.2 Million
Float: 17 Million
Sector: Health Technology
Industry: Medical Specialties
Longest drawdown: 782 trading days
From: 2013-02-15 To: 2016-03-29
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|